Partner Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Partner Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-61,250	Closed	-$1.63M	–	125
2018 Q3	$1.63M	Sell	61,250 -7,558	-11%	-$247K	1.25%	29
2018 Q2	$2.6M	Sell	68,808 -3,476	-5%	-$133K	2.1%	9
2018 Q1	$2.36M	Sell	72,284 -12,833	-15%	-$563K	2.55%	7
2017 Q4	$4.14M	Buy	85,117 +3,548	+4%	+$179K	4.77%	3
2017 Q3	$4.41M	Buy	81,569 +29,300	+56%	+$1.72M	4.18%	3
2017 Q2	$2.94M	Buy	52,269 +16,907	+48%	+$677K	3.94%	2
2017 Q1	$1.39M	Buy	35,362 +20,890	+144%	+$665K	1.69%	22
2016 Q4	$325K	Buy	+14,472	New	+$283K	0.43%	67

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Partner Investment Management's PTLA Position: Q4 2018 in Review

Partner Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 61,250 shares — an estimated $1.63M sold.

Partner Investment Management first reported a position in PTLA in Q4 2016 and held it in 8 quarters. The position peaked at $4.41M in Q3 2017. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

Partner Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Partner Investment Management sold 61,250 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $1.63M.
Partner Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2016 and held it in 8 quarters.
Partner Investment Management's Portola Pharmaceuticals, Inc. position peaked at $4.41M in Q3 2017.
181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.